• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于艾滋病疫苗研发的重组 gp120 的非亲和纯化。

Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development.

作者信息

Scandella C J, Kilpatrick J, Lidster W, Parker C, Moore J P, Moore G K, Mann K A, Brown P, Coates S, Chapman B

机构信息

Department of Process Development, Chiron Corporation, Emeryville, California 94608.

出版信息

AIDS Res Hum Retroviruses. 1993 Dec;9(12):1233-44. doi: 10.1089/aid.1993.9.1233.

DOI:10.1089/aid.1993.9.1233
PMID:8142140
Abstract

The gene encoding the major envelope glycoprotein of the HIV-SF2 isolate was engineered for the secretion of recombinant gp120 (rgp120SF2) from permanent Chinese hamster ovary (CHO) cell lines. Cellular production methods were scaled up and a method for purification of the secreted glycoprotein was devised. Mild purification conditions were selected in order to preserve the native structure of the protein. rgp120SF2 exhibits a molecular weight of 120 kDa in reduced or nonreduced SDS gels; thus the polypeptide chain is intact. Deglycosylated rgp120SF2 has the predicted molecular weight of the polypeptide backbone, 54 kDa. Gel-filtration HPLC in a nondenaturing buffer at neutral pH yields a molecular weight estimate of approximately 120 kDa. Purified rgp120 closely resembles authentic viral gp120 by several physical, chemical, and immunochemical tests. rgp120SF2 reacts strongly with human HIV-positive sera, monoclonal antibodies reactive with HIV-SF2 and HIV-MN viral envelope, and a human virus-neutralizing monoclonal antibody that maps to a conserved discontinuous epitope on HIV-1 gp120. Purified rgp120SF2 forms a 1:1 molecular complex with soluble recombinant human CD4 (rCD4) receptor, as demonstrated by gel-filtration HPLC; binding is high affinity (Kd approximately 2 x 10(-9) M).

摘要

对编码HIV - SF2分离株主要包膜糖蛋白的基因进行了改造,以便从中国仓鼠卵巢(CHO)永久细胞系中分泌重组gp120(rgp120SF2)。扩大了细胞生产方法的规模,并设计了一种分泌糖蛋白的纯化方法。选择温和的纯化条件以保留蛋白质的天然结构。在还原或非还原SDS凝胶中,rgp120SF2的分子量为120 kDa;因此多肽链是完整的。去糖基化的rgp120SF2具有多肽主链的预测分子量,即54 kDa。在中性pH的非变性缓冲液中进行凝胶过滤HPLC,得出的分子量估计约为120 kDa。通过多项物理、化学和免疫化学测试,纯化的rgp120与天然病毒gp120非常相似。rgp120SF2与人类HIV阳性血清、与HIV - SF2和HIV - MN病毒包膜反应的单克隆抗体以及一种针对HIV - 1 gp120上保守的不连续表位的人类病毒中和单克隆抗体强烈反应。如凝胶过滤HPLC所示,纯化的rgp120SF2与可溶性重组人CD4(rCD4)受体形成1:1分子复合物;结合具有高亲和力(解离常数约为2×10⁻⁹ M)。

相似文献

1
Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development.用于艾滋病疫苗研发的重组 gp120 的非亲和纯化。
AIDS Res Hum Retroviruses. 1993 Dec;9(12):1233-44. doi: 10.1089/aid.1993.9.1233.
2
The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.HIV-1 gp120 IIIB/LAI的V3环中低轮廓丝氨酸取代对包膜蛋白免疫原性的影响。
Virology. 1998 Nov 10;251(1):59-70. doi: 10.1006/viro.1998.9392.
3
Importance of conformation on the neutralizing antibody response to HIV-1 gp120.构象对HIV-1 gp120中和抗体反应的重要性。
Biotechnol Ther. 1991;2(1-2):63-89.
4
Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies.用于HIV疫苗研究的重组gp120的高效纯化及严格表征
Vaccine. 1995 Aug;13(11):991-9. doi: 10.1016/0264-410x(95)00019-w.
5
Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters.基于十四种野生型gp120蛋白的多价HIV-1候选疫苗在金黄仓鼠中的免疫原性。
BMC Immunol. 2006 Oct 31;7:25. doi: 10.1186/1471-2172-7-25.
6
DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.表达与C3d融合的可溶性CD4包膜蛋白的DNA疫苗可引发针对HIV-1的交叉反应性中和抗体。
Virology. 2004 Oct 25;328(2):292-300. doi: 10.1016/j.virol.2004.07.031.
7
Inhibition of V3-specific cleavage of recombinant HIV-1 gp120 produced in Chinese hamster ovary cells.对中国仓鼠卵巢细胞中产生的重组HIV-1 gp120的V3特异性切割的抑制作用。
Protein Expr Purif. 2008 Jun;59(2):223-31. doi: 10.1016/j.pep.2008.02.002. Epub 2008 Feb 21.
8
MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group.MN和IIIB重组糖蛋白120疫苗诱导产生针对1型人类免疫缺陷病毒原始分离株天然包膜糖蛋白的结合抗体。美国国立过敏和传染病研究所艾滋病疫苗评估小组。
AIDS Res Hum Retroviruses. 1999 Jul 1;15(10):921-30. doi: 10.1089/088922299310638.
9
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。
Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.
10
Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.基于CD4的分子与针对gp120或gp41的抗体联合对HIV-1包膜介导的细胞融合的协同抑制作用。
AIDS Res Hum Retroviruses. 1993 Jul;9(7):581-7. doi: 10.1089/aid.1993.9.581.

引用本文的文献

1
Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells.鉴定和 CRISPR/Cas9 敲除负责 CHO 细胞中重组蛋白蛋白水解的 C1s 蛋白酶。
Biotechnol Bioeng. 2019 Sep;116(9):2130-2145. doi: 10.1002/bit.27016. Epub 2019 Jun 10.
2
Development of a Stable MGAT1 CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies.开发稳定的 MGAT1 CHO 细胞系以生产与广泛中和抗体结合能力提高的 clade C gp120。
Front Immunol. 2018 Oct 5;9:2313. doi: 10.3389/fimmu.2018.02313. eCollection 2018.
3
Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120.
全长糖基化单体 HIV gp120 的溶液结构、构象动力学和 CD4 诱导激活。
J Virol. 2012 Aug;86(16):8750-64. doi: 10.1128/JVI.07224-11. Epub 2012 Jun 6.
4
Tracking hydrogen/deuterium exchange at glycan sites in glycoproteins by mass spectrometry.通过质谱法追踪糖蛋白中糖基位点的氢/氘交换。
Anal Chem. 2011 Oct 1;83(19):7492-9. doi: 10.1021/ac201729v. Epub 2011 Sep 6.
5
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.一种可溶性三聚体包膜蛋白的纯化、特性鉴定及免疫原性研究,该蛋白包含来自R5嗜性1型人类免疫缺陷病毒分离株SF162的V2环部分缺失。
J Virol. 2003 Oct;77(20):11244-59. doi: 10.1128/jvi.77.20.11244-11259.2003.
6
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.一种经蛋白酶成熟、二硫键稳定的人类免疫缺陷病毒1型gp140包膜糖蛋白的寡聚体和构象特性
J Virol. 2002 Aug;76(15):7760-76. doi: 10.1128/jvi.76.15.7760-7776.2002.
7
Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.来自原发性R5 B亚型人类免疫缺陷病毒的寡聚包膜糖蛋白的纯化与鉴定
J Virol. 2002 Mar;76(6):2835-47. doi: 10.1128/jvi.76.6.2835-2847.2002.
8
Gp120 activates children's brain endothelial cells via CD4.Gp120通过CD4激活儿童脑内皮细胞。
J Neurovirol. 2001 Apr;7(2):125-34. doi: 10.1080/13550280152058780.
9
Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis.趋化因子与HIV gp120诱导的神经元凋亡中的活化巨噬细胞
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8212-6. doi: 10.1073/pnas.96.14.8212.
10
Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.人类免疫缺陷病毒(HIV)包膜可独立于CD4与CXCR4结合,与可溶性CD4相互作用或HIV包膜去糖基化可增强这种结合。
J Virol. 1998 Mar;72(3):2500-4. doi: 10.1128/JVI.72.3.2500-2504.1998.